DRAK1/2-IN-2
DRAK1/2-IN-2 (Compound Y17) is a DRAK1/2 inhibitor with IC50 values for DRAK2 and DRAK1 of 353.2 nM and 507.4 nM respectively. DRAK1/2-IN-2 can enhance mitochondrial membrane potential and glucose-stimulated insulin secretion (GSIS). DRAK1/2-IN-2 resists lipotoxicity-induced cell apoptosis. DRAK1/2-IN-2 significantly inhibits the secretion of pro-inflammatory cytokine IL-1β, thereby exerting an anti-inflammatory effect. DRAK1/2-IN-2 can significantly lower the blood glucose levels of mice. DRAK1/2-IN-2 can be used in diabetes research.
For research use only. We do not sell to patients.
- Formula: C24H27N3O4S
- Molecular Weight:453.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Endogenous Metabolite Isoforms
More
Biological Activity
|
DAPK1 507.4 nM (IC50) |
DAPK2 353.2 nM (IC50) |
IL-1β |
Chemical Information
-
Molecular Weight 453.55
-
Formula C24H27N3O4S
-
SMILES
O=C(NC1=CSC2=NC=C(C=C12)C(C=C3OC)=CC=C3NCCC(O)=O)C4CCCCC4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)